• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏淀粉样变性组织病理学模式的临床意义

Clinical significance of histopathologic patterns of cardiac amyloidosis.

作者信息

Smith T J, Kyle R A, Lie J T

出版信息

Mayo Clin Proc. 1984 Aug;59(8):547-55. doi: 10.1016/s0025-6196(12)61493-1.

DOI:10.1016/s0025-6196(12)61493-1
PMID:6748745
Abstract

Cardiac amyloidosis may be asymptomatic or an important cause of progressive heart failure and refractory arrhythmia. To identify the morphologic markers of clinically significant cardiac amyloidosis, we analyzed the hearts of 47 patients with autopsy-proven cardiac amyloidosis (21 with primary amyloidosis [AL] and 26 with senile cardiac amyloidosis [SCA]) histologically for the extent and pattern of amyloid deposits. The extent of amyloid deposition was graded 1 through 4, corresponding with less than 10%, 10 to 25%, 26 to 50%, and more than 50% histologic involvement of the myocardium, respectively. The pattern of deposits was classified as nodular, perifiber, or mixed type, and the presence or absence of vascular involvement was determined. The hearts with primary amyloidosis showed predominantly high-grade deposits (76% grades 3 and 4), a perifiber (65%) or mixed (30%) pattern of deposits, and frequent (90%) vascular involvement. The hearts with senile cardiac amyloidosis tended to have low-grade deposits (62% grades 1 and 2), a nodular pattern (92%) of deposits, and infrequent (4%) vascular involvement. Clinically significant cardiac amyloidosis was associated with grade 2 or greater amyloid deposits in the heart and with involvement of intramyocardial arterioles.

摘要

心脏淀粉样变性可能无症状,也可能是进行性心力衰竭和难治性心律失常的重要原因。为了确定具有临床意义的心脏淀粉样变性的形态学标志物,我们对47例经尸检证实为心脏淀粉样变性的患者(21例原发性淀粉样变性[AL]和26例老年心脏淀粉样变性[SCA])的心脏进行了组织学分析,以了解淀粉样蛋白沉积的范围和模式。淀粉样蛋白沉积的程度分为1至4级,分别对应心肌组织学累及小于10%、10%至25%、26%至50%和大于50%。沉积物的模式分为结节状、纤维周围型或混合型,并确定是否存在血管受累。原发性淀粉样变性的心脏主要表现为高级别沉积(76%为3级和4级)、纤维周围(65%)或混合(30%)沉积模式,以及频繁(90%)的血管受累。老年心脏淀粉样变性的心脏倾向于低级别沉积(62%为1级和2级)、结节状沉积模式(92%)和罕见(4%)的血管受累。具有临床意义的心脏淀粉样变性与心脏中2级或更高等级的淀粉样蛋白沉积以及心肌内小动脉受累有关。

相似文献

1
Clinical significance of histopathologic patterns of cardiac amyloidosis.心脏淀粉样变性组织病理学模式的临床意义
Mayo Clin Proc. 1984 Aug;59(8):547-55. doi: 10.1016/s0025-6196(12)61493-1.
2
Histomorphometric analysis of intramyocardial vessels in primary and senile amyloidosis: epicardium versus endocardium.原发性和老年性淀粉样变性中心肌内血管的组织形态计量学分析:心外膜与心内膜的比较
Cardiovasc Pathol. 2008 Mar-Apr;17(2):65-71. doi: 10.1016/j.carpath.2007.05.008. Epub 2007 Oct 31.
3
Visceral organ involvement and extracellular matrix changes in beta 2-microglobulin amyloidosis--a comparative study with systemic AA and AL amyloidosis.β2-微球蛋白淀粉样变性中的内脏器官受累及细胞外基质变化——与系统性AA型和AL型淀粉样变性的比较研究
Virchows Arch. 1997 Jun;430(6):479-87. doi: 10.1007/s004280050058.
4
Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients.心脏免疫细胞源性(AL)淀粉样变性:11例患者的心内膜心肌活检研究
Am Heart J. 1995 Sep;130(3 Pt 1):528-36. doi: 10.1016/0002-8703(95)90362-3.
5
Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.心脏淀粉样变性中的延迟钆增强:既归因于间质淀粉样蛋白沉积,也归因于缺血引起的心内膜下纤维化。
Heart Vessels. 2016 Jun;31(6):990-5. doi: 10.1007/s00380-015-0658-0. Epub 2015 Mar 21.
6
[Histopathological study of valvular deposits of amyloid protein in cardiac amyloidosis].[心脏淀粉样变性中瓣膜淀粉样蛋白沉积的组织病理学研究]
J Cardiol. 1996;27 Suppl 2:31-7; discussion 38.
7
Pathology of amyloidosis and amyloid heart disease.淀粉样变性及淀粉样心脏病的病理学
Appl Pathol. 1984;2(6):341-56.
8
[Classification of cardiac amyloidosis: an immunohistochemical analysis].[心脏淀粉样变性的分类:免疫组织化学分析]
Zhonghua Bing Li Xue Za Zhi. 2018 Feb 8;47(2):105-109. doi: 10.3760/cma.j.issn.0529-5807.2018.02.005.
9
Manifestation and ultrastructural typing of amyloid deposits in the heart.心脏中淀粉样沉积物的表现及超微结构分型
Virchows Arch A Pathol Anat Histopathol. 1983;401(2):185-201. doi: 10.1007/BF00692644.
10
Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study.老年系统性淀粉样变的临床病理特征:一项生前和死后的研究。
Mod Pathol. 2011 Dec;24(12):1533-44. doi: 10.1038/modpathol.2011.117. Epub 2011 Aug 5.

引用本文的文献

1
Trends in incidence and clinical outcome of non-ST elevation myocardial infarction in patients with amyloidosis in the United States, 2010-2020.2010 - 2020年美国淀粉样变性患者非ST段抬高型心肌梗死的发病率及临床结局趋势
Am Heart J Plus. 2023 Oct 23;35:100336. doi: 10.1016/j.ahjo.2023.100336. eCollection 2023 Nov.
2
Amyloid Burden Correlates with Electrocardiographic Findings in Patients with Cardiac Amyloidosis-Insights from Histology and Cardiac Magnetic Resonance Imaging.淀粉样蛋白负荷与心脏淀粉样变性患者的心电图表现相关——来自组织学和心脏磁共振成像的见解
J Clin Med. 2024 Jan 9;13(2):368. doi: 10.3390/jcm13020368.
3
Valvular heart disease in patients with cardiac amyloidosis.
心脏淀粉样变患者的瓣膜性心脏病。
Heart Fail Rev. 2024 Jan;29(1):65-77. doi: 10.1007/s10741-023-10350-1. Epub 2023 Sep 22.
4
Prevalence, incidence and clinical outcomes of epicardial coronary artery disease among transthyretin amyloidosis cardiomyopathy patients.转甲状腺素蛋白淀粉样变心肌病患者心外膜冠状动脉疾病的患病率、发病率和临床结局。
BMC Cardiovasc Disord. 2023 Mar 8;23(1):124. doi: 10.1186/s12872-023-03140-y.
5
The flutemetamol analogue cyano-flutemetamol detects myocardial AL and ATTR amyloid deposits: a post-mortem histofluorescence analysis.氰基-氟曲美他胺类似物氟曲美他胺可检测心肌 AL 和 ATTR 淀粉样沉积物:死后组织荧光分析。
Amyloid. 2023 Jun;30(2):169-187. doi: 10.1080/13506129.2022.2141623. Epub 2022 Nov 21.
6
Assessment and Management of Older Patients With Transthyretin Amyloidosis Cardiomyopathy: Geriatric Cardiology, Frailty Assessment and Beyond.转甲状腺素蛋白淀粉样变心肌病老年患者的评估与管理:老年心脏病学、衰弱评估及其他
Front Cardiovasc Med. 2022 May 17;9:863179. doi: 10.3389/fcvm.2022.863179. eCollection 2022.
7
Prevalence and haemodynamic profiles of pulmonary hypertension in cardiac amyloidosis.心脏淀粉样变性中肺动脉高压的患病率和血液动力学特征。
Open Heart. 2022 Mar;9(1). doi: 10.1136/openhrt-2021-001808.
8
Echocardiographic assessment of cardiac amyloidosis.超声心动图评估心脏淀粉样变性。
Heart Fail Rev. 2022 Sep;27(5):1505-1513. doi: 10.1007/s10741-021-10165-y. Epub 2021 Aug 30.
9
Clinical Outcomes and Disease Burden in Amyloidosis Patients with and Without Atrial Fibrillation-Insight from the National Inpatient Sample Database.心房颤动患者与非心房颤动患者淀粉样变性的临床结局和疾病负担——来自国家住院样本数据库的见解
J Innov Card Rhythm Manag. 2021 Jun 15;12(6):4542-4549. doi: 10.19102/icrm.2021.120605. eCollection 2021 Jun.
10
Increased inpatient mortality in patients hospitalized for atrial fibrillation and atrial flutter with concomitant amyloidosis: Insight from National Inpatient Sample (NIS) 2016-2017.因心房颤动和心房扑动合并淀粉样变性住院患者的住院死亡率增加:来自2016 - 2017年全国住院患者样本(NIS)的见解
Indian Pacing Electrophysiol J. 2021 Nov-Dec;21(6):344-348. doi: 10.1016/j.ipej.2021.06.005. Epub 2021 Jun 19.